Mobile Menu

Drugging the cancer genome: progress, opportunities and challenges in personalised medicine

Drugging the cancer genome: progress, opportunities and challenges in personalised medicine
Paul Workman,
Professor of Pharmacology and Therapeutics, Institute of Cancer Research

You may also like

The Forefront of Genomics: Opportunities, Challenges, and Imperatives
Eric Green, Director, National Human Genome Research Institute (NHGRI)
All of Us Research Program: Advancing Precision Health for All Populations
Stephanie Devaney, Chief Operating Officer, All of Us Research Programme,National Institutes of Health (NIH)
Rare Disease as an Emerging Field of Medicine
Marshall Summar, Director, Rare Disease Institute, Children’s National Health System
UK Biobank: Going Beyond Genomics in 2022
Mark Effingham, Deputy Chief Executive Officer, UK Biobank
The Future of Genomics: Health and Beyond
Sir Patrick Vallance, Government Chief Scientific Adviser, UK Government
How Genomics is Changing the Shape of Healthcare: England’s NHS Continues its Momentum
Dame Sue Hill, Chief Scientific Officer, NHS England and NHS Improvement

Page 2 of 2

Share this article